Cas:383136-44-5 1-pyridin-2-ylpyrrole-2-carbaldehyde manufacturer & supplier

We serve Chemical Name:1-pyridin-2-ylpyrrole-2-carbaldehyde CAS:383136-44-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-pyridin-2-ylpyrrole-2-carbaldehyde

Chemical Name:1-pyridin-2-ylpyrrole-2-carbaldehyde
CAS.NO:383136-44-5
Synonyms:1-(2-pyridyl)pyrrole-2-carbaldehyde;1-(pyridin-2-yl)-1H-pyrrole-2-carbaldehyde
Molecular Formula:C10H8N2O
Molecular Weight:172.18300
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:338.7ºC at 760 mmHg
Density:1.15g/cm3
Index of Refraction:1.604
PSA:34.89000
Exact Mass:172.06400
LogP:1.68480

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-(2-pyridyl)pyrrole-2-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(pyridin-2-yl)-1H-pyrrole-2-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(pyridin-2-yl)-1H-pyrrole-2-carbaldehyde Use and application,1-(2-pyridyl)pyrrole-2-carbaldehyde technical grade,usp/ep/jp grade.


Related News: The US-based study is evaluating the effect of ensifentrine on key outcomes in patients hospitalised with COVID-19, including facilitation of recovery from the viral infection, clinical status improvement and reduction in supplemental oxygen use and progression to mechanical ventilation. 4-(trifluoromethoxy)benzene-1,2-diamine dihydrochloride manufacturers Biogen’s top research chief, Dr. Al Sandrock, defended the drug in an open letter released alongside the company’s earnings Thursday, saying its approval has been subject to “extensive misinformation and misunderstanding.” (S)-3-Hydroxy-2-((Z)-2-{[(S)-1-((S)-piperidine-2-carbonyl)-pyrrolidine-2-carbonyl]-amino}-but-2-enoylamino)-propionic acid suppliers In the US, avalglucosidase alfa saw its PDUFA date pushed back by three months, from May 18 to Aug. 18, according to a Sanofi investor presentation in April. 2-Chloro-4-dimethylamino-5-fluorophenylboronic acid vendor & factory.